Latest Whitepapers

This article presents current techniques in oligonucleotide production and characterization, highlighting recent advancements that enhance the efficiency of these methods

This whitepaper explores the key steps in the antibody development process and highlights how partnership with an expert manufacturing service provider can help to simplify and expedite your workflow.

The diagnostic industry is a crucial pillar of modern healthcare. It equips clinicians with vital tools and provides consumers with a range of at-home testing solutions. This whitepaper features industry experts in discussing the key challenges in diagnostics and how to tackle them.

This whitepaper explores the latest reagents and software available to enhance tumor exome profiling for the generation of accurate, actionable clinical insights.

While the industry was put front and center during the COVID-19 pandemic, diagnostics have always been critical in treating illnesses and managing health. Technological advances, innovative platforms, and decentralized test options are driving exciting developments and optimism across the diagnostics industry.

Novice and expert in vitro diagnostics (IVD) manufacturers agree that developing, optimizing, and launching a lateral flow assay (LFA) test is never routine nor easy.

The SomaScan Assay is an ideal high throughput platform for identifying proteins that may be involved in disease pathology, as it offers a highly sensitive method of quantifying proteins in different biologic fluids such as serum, plasma, urine and cerebrospinal fluid.

In this whitepaper, learn how the innovative features of the cobas t 711 coagulation analyzer address the need for greater efficiency, improved workflow and reliable results, potentially allowing laboratory staff to gain more time to focus on validation and clinical interpretation.

Only a small amount of cell-free DNA (cfDNA) can be found in circulation, therefore efficient and highly sensitive technologies such as next-generation sequencing (NGS) are typically being used to detect this biomarker.

The need for molecular diagnostic assays is growing at an unprecedented rate and the discovery of new biomarkers and improved accessibility to standard catalog reagents has allowed the creation of molecular tests faster than ever before.